Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells.

Kalin, Seyda Nur; Altay, Ahmet; Budak, Harun

Kalin, Seyda Nur; Altay, Ahmet; Budak, Harun.

Afiliación

Kalin SN; Atatürk University, Science Faculty, Department of Molecular Biology and Genetics, 25240, Erzurum, Turkey; Atatürk University, East Anatolia High Technology Application and Research Center (DAYTAM), 25240, Erzurum, Turkey.
Altay A; Erzincan Binali Yildirim University, Faculty of Science and Arts, Department of Chemistry, 24002, Erzincan, Turkey.
Budak H; Atatürk University, Science Faculty, Department of Molecular Biology and Genetics, 25240, Erzurum, Turkey; Atatürk University, East Anatolia High Technology Application and Research Center (DAYTAM), 25240, Erzurum, Turkey. Electronic address: hbudak@atauni.edu.tr.

Chem Biol Interact ; 361: 109984, 2022 Jul 01.

Article en En | MEDLINE | ID: mdl-35569514

Asunto(s)

Neoplasias de la Mama; Tiorredoxina Reductasa 1; Anisoles; Apoptosis; Neoplasias de la Mama/patología; Línea Celular Tumoral; Proliferación Celular; Femenino; Humanos; Hidroxibenzoatos/farmacología

Palabras clave

Breast cancer; Diffractaic acid; Enzyme activity; Expression; Lichens; Thioredoxin reductase 1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_breast_cancer Asunto principal: Neoplasias de la Mama / Tiorredoxina Reductasa 1 Límite: Female / Humans Idioma: En Revista: Chem Biol Interact Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google